New York City’s Javits Center offering COVID-19 vaccinations 24/7 – Everett Post

By MARLENE LENTHANG, ABC News

(NEW YORK) – The Javits Center in New York City is now open 24 hours a day, seven days a week after the vaccine was approved by Johnson & Johnson a week ago.

The Manhattan Convention Center takes appointments around the clock to vaccinate New Yorkers as soon as possible. Efforts began at 9:00 p.m. Friday, with the Johnson & Johnson vaccine only being distributed overnight from 9:00 p.m. to 6:00 a.m.

According to the ABC New York broadcaster WABC, the doses of the new vaccine, which, unlike the two-dose vaccines Moderna and Pfizer-BioNTech, only requires one shot, arrived in New York during the week.

Yankee Stadium in the Bronx and the New York State Fair grounds in Syracuse are additional venues that dispense vaccines around the clock. The Johnson & Johnson vaccine is also used overnight.

According to state data, more than 3.3 million New Yorkers have received at least one dose of vaccine. Over 1.7 million people, or 8.8% of the state, are fully vaccinated.

Earlier this week, the convention center announced that it had distributed 100,000 vaccinations since it first became a vaccination center in January. Almost a year ago, the Javits Center was serving as the COVID-19 field hospital when the coronavirus crisis first struck the country.

About 17% of the US population are partially vaccinated and 8.6% are fully vaccinated, according to the Centers for Disease Control and Prevention. California has given the most vaccines, according to the CDC, followed by Texas, Florida, New York, Illinois, and Pennsylvania.

Three different vaccines are used in the US – from Johnson & Johnson, Pfizer-BioNTech, and Moderna

In clinical studies, the Johnson & Johnson vaccine was 85% effective in preventing severe / critical illness and 66% effective in preventing symptomatic illness 28 days after vaccination. Importantly, it was 100% effective in preventing hospital stays and death from COVID-19.

Pfizer-BioNTech and Moderna vaccines are 95% and 94.1% effective in preventing symptomatic disease, respectively. However, they were tested before the new, contagious variants emerged. The Johnson & Johnson vaccine was tested against the new variants and still performed well.